Comparing Two School-Based Sleep Health Interventions To Promote Sleep Quality in Youth
2 other identifiers
interventional
1,320
1 country
2
Brief Summary
The goal of this clinical trial is to conduct a comparative effectiveness trial that will evaluate two school-based interventions to improve adolescent sleep health: the standard Sleep Health Education (SHE) and a stepped care version of the Transdiagnostic Sleep and Circadian intervention (TS-C-STEP). The main questions it aims to answer \[is/are\]:
- TS-C-STEP will yield superior outcomes relative to SHE at post-treatment and up to 12 months following treatment.
- In this large and diverse sample, vulnerable subgroups (e.g. socioeconomically disadvantaged, racial, ethnic, rural, and youth with comorbid learning and/or mental health conditions) will experience greater benefits from TS-C-STEP compared to SHE on primary and secondary outcomes. Researchers will compare sleep quality to determine which intervention is most effective.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2026
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 29, 2025
CompletedFirst Posted
Study publicly available on registry
October 9, 2025
CompletedStudy Start
First participant enrolled
March 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2030
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 1, 2030
February 24, 2026
February 1, 2026
3.9 years
September 29, 2025
February 23, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from baseline for total score sleep quality using the Pittsburgh Sleep Quality Index.
A self-rated questionnaire which assesses sleep quality and disturbances over a 1-month time interval. The sum of scores yields one global score with a minimum score of 0 and a maximum score of 21. A higher score indicates more self-reported sleep problems.
Baseline to 14 months
Secondary Outcomes (8)
Change from baseline for total insomnia severity score sleep health using the insomnia severity index.
Baseline to 14 months
Change from baseline for total evening circadian preference score sleep health using the Children's Morningness and Eveningness Preference.
Baseline to 14 months
Change from baseline for total sleep related impairment score sleep health using the PROMIS sleep related impairment questionnaire.
Baseline to 14 months
Change from baseline for sleep duration estimates from sleep diaries.
Baseline to 14 months
Change from baseline for quality of life and functioning using the PROMIS Global Health Questionnaire.
Baseline to 14 months
- +3 more secondary outcomes
Study Arms (2)
Sleep Health Education (SHE)
ACTIVE COMPARATORParticipants will be given access to a program, developed for the proposed project, with American Academy of Sleep Medicine (AASM) videos, worksheets and sleep diaries aimed to improve sleep health.
Transdiagnostic Sleep and Circadian intervention (TS-C-STEP
EXPERIMENTALIn the TS-C-STEP condition, all participants initially are given access to the TS-C program. TS-C is an evidence based cognitive behavioral sleep intervention. Youth will be stepped up to higher levels of care dependent on their progress with the program.
Interventions
Cognitive behavioral sleep intervention.
Eligibility Criteria
You may qualify if:
- Age 12-18 years old
- Sleep health problem (i.e. insomnia, evening circadian preference, short sleep duration, poor sleep quality)
- Able to participate in a general education classroom.
You may not qualify if:
- Previous participation in the study;
- Symptoms or illness that precludes informed consent or engagement in study procedures ; youth not fluent in English, parent not fluent in English, or Spanish.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Children's Hospital Los Angeleslead
- Nationwide Children's Hospitalcollaborator
Study Sites (2)
Children's Hospital Los Angeles
Los Angeles, California, 90027, United States
Nationwide Children's Hospital
Columbus, Ohio, 43205, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Lauren Asarnow,, PhD
Children's Hospital Los Angeles
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Medical Staff/USC Faculty CWR • Neurology CWR
Study Record Dates
First Submitted
September 29, 2025
First Posted
October 9, 2025
Study Start
March 1, 2026
Primary Completion (Estimated)
February 1, 2030
Study Completion (Estimated)
June 1, 2030
Last Updated
February 24, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL